Organicell Regenerative Medicine (BPSR) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free BPSR Stock Alerts $1.41 +0.01 (+0.71%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesInsider TradesSEC FilingsStock AnalysisChartFinancialsHeadlinesInsider TradesSEC Filings Organicell Regenerative Medicine Short Interest DataCurrent Short Volume70,800 sharesPrevious Short Volume2,300 sharesChange Vs. Previous Month+2,978.26%Dollar Volume Sold Short$4,318.80Short Interest Ratio / Days to Cover0.0Last Record DateOctober 29, 2021Today's Trading Volume128 sharesAverage Trading Volume3,307,506 sharesToday's Volume Vs. Average0% Short Selling Organicell Regenerative Medicine ? Sign up to receive the latest short interest report for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBPSR Short Interest Over TimeBPSR Days to Cover Over TimeBPSR Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Organicell Regenerative Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/29/202170,800 shares $4,318.80 +2,978.3%N/A0 $0.06 10/15/20212,300 shares $135.01 +228.6%N/A0 $0.06 9/30/2021700 shares $56.70 -96.5%N/A0 $0.08 9/15/202119,800 shares $1,752.30 -83.7%N/A0 $0.09 8/31/2021121,500 shares $11,238.75 +793.4%N/A0 $0.09 8/13/202113,600 shares $1,317.84 -85.5%N/A0 $0.10 Get the Latest News and Ratings for BPSR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter. 7/30/202194,000 shares $9,663.20 +171.7%N/A0 $0.10 7/15/202134,600 shares $3,771.40 -39.7%N/A0 $0.11 6/30/202157,400 shares $8,380.40 +94.6%N/A0 $0.15 6/15/202129,500 shares $4,427.95 -51.8%N/A0 $0.15 5/28/202161,200 shares $11,016.00 -61.9%N/A0 $0.18 5/14/2021160,600 shares $39,507.60 +13.6%N/A0 $0.25 4/30/2021141,400 shares $84,133.00 +1,388.4%N/A0 $0.60 4/15/20219,500 shares $541.50 -72.9%N/A0 $0.06 3/31/202135,100 shares $2,009.48 +322.9%N/A0 $0.06 3/15/20218,300 shares $704.67 -52.6%N/A0 $0.08 2/26/202117,500 shares $1,538.25 +280.4%N/A0 $0.09 2/12/20214,600 shares $494.50 -91.2%N/A0 $0.11 1/29/202152,500 shares $5,197.50 -26.1%N/A0 $0.10 1/15/202113,300 shares $1,356.60 -81.5%N/A0 $0.10 12/31/20204,100 shares $639.60 -69.2%N/A0 $0.16 12/15/202013,300 shares $2,021.60 -81.5%N/A0 $0.15 11/30/202071,900 shares $9,347.00 +310.9%N/A0.2 $0.13 11/15/202017,500 shares $1,925.00 +446.9%N/A0 $0.11 10/30/20203,200 shares $560.00 +33.3%N/A0 $0.18 10/15/20202,400 shares $576.00 -52.9%N/A0 $0.24 9/30/20205,100 shares $1,326.00 -84.8%N/A0 $0.26 9/15/202033,600 shares $11,424.00 +102.4%N/A0 $0.34 8/31/202016,600 shares $4,506.90 +191.2%N/A0 $0.27 8/14/20205,700 shares $729.60 -76.8%N/A0 $0.13 7/31/202024,600 shares $1,230.00 +530.8%N/A0 $0.05 7/15/20203,900 shares $257.40 +8.3%N/A0 $0.07 6/30/20203,600 shares $172.80 No ChangeN/A0 $0.05 5/29/202049,900 shares $4,241.50 +679.7%N/A0 $0.09 5/15/20206,400 shares $256.00 No ChangeN/A0 $0.04 4/15/202012,800 shares $281.60 +156.0%N/A0 $0.02 3/31/20205,000 shares $130.00 No ChangeN/A0.2 $0.03 3/13/20205,000 shares $160.50 No ChangeN/A0.1 $0.03 1/31/2020200 shares $5.40 -88.2%N/A0 $0.03 1/15/20201,700 shares $51.00 -68.5%N/A0 $0.03top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… BPSR Short Interest - Frequently Asked Questions What is Organicell Regenerative Medicine's current short interest? Short interest is the volume of Organicell Regenerative Medicine shares that have been sold short but have not yet been closed out or covered. As of October 29th, traders have sold 70,800 shares of BPSR short. Learn More on Organicell Regenerative Medicine's current short interest. Is Organicell Regenerative Medicine's short interest increasing or decreasing? Organicell Regenerative Medicine saw a increase in short interest during the month of October. As of October 29th, there was short interest totaling 70,800 shares, an increase of 2,978.3% from the previous total of 2,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($8.61 billion), Advanced Micro Devices, Inc. ($8.44 billion), Charter Communications, Inc. ($5.26 billion), Canadian Pacific Kansas City Limited ($5.13 billion), Wayfair Inc. ($4.34 billion), Uber Technologies, Inc. ($3.69 billion), Palo Alto Networks, Inc. ($3.35 billion), Teladoc Health, Inc. ($3.11 billion), eBay Inc. ($2.91 billion), and Etsy, Inc. ($2.63 billion). View all of the most shorted stocks. What does it mean to sell short Organicell Regenerative Medicine stock? Short selling BPSR is an investing strategy that aims to generate trading profit from Organicell Regenerative Medicine as its price is falling. BPSR shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organicell Regenerative Medicine? A short squeeze for Organicell Regenerative Medicine occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPSR, which in turn drives the price of the stock up even further. How often is Organicell Regenerative Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPSR, twice per month. The most recent reporting period available is October, 29 2021. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Interest Data 3SBio Short Interest Data Abcam Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Apollomics Short Interest Data Artelo Biosciences Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Avacta Group Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BPSR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society